1. Home
  2. MNDO vs BOLD Comparison

MNDO vs BOLD Comparison

Compare MNDO & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.16

Market Cap

24.2M

Sector

Technology

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.13

Market Cap

28.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
BOLD
Founded
1995
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
28.4M
IPO Year
2000
2024

Fundamental Metrics

Financial Performance
Metric
MNDO
BOLD
Price
$1.16
$1.13
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
26.1K
178.1K
Earning Date
03-03-2026
03-26-2026
Dividend Yield
19.30%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$19,770,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.96
52 Week High
$2.13
$2.48

Technical Indicators

Market Signals
Indicator
MNDO
BOLD
Relative Strength Index (RSI) 40.69 41.72
Support Level $1.19 $0.96
Resistance Level $1.25 $1.20
Average True Range (ATR) 0.05 0.07
MACD -0.01 -0.01
Stochastic Oscillator 0.09 46.87

Price Performance

Historical Comparison
MNDO
BOLD

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: